PND31 A Modelled Economic Evaluation of Firazyr® (Icatibant) for Symptomatic Treatment of Acute Attacks of Hereditary Angioedema (HAE) in Adults with C1-Esterase-Inhibitor (C1-INH) Deficiency
Abstract
Authors
D. Tilden S. Cottrell L. Tocchini N. Jayaram R. Sinani D. Barnes